Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Over allotment facililty

15 May 2018 16:05

RNS Number : 1784O
Amati AIM VCT PLC
15 May 2018
 

Amati AIM VCT plc

Legal Entity Identifier: 213800HAEDBBK9RWCD25

 

Amati AIM VCT plc (the "Company")

As announced on 12 April 2018, the joint fundraising launched in October 2017 by Amati VCT plc and Amati VCT 2 plc has reached its target of £20m and the Offers are now closed to new subscriptions. However, the Company had already received and accepted certain applications to subscribe for shares in Amati VCT plc prior to the merger between Amati VCT plc and Amati VCT 2 plc, and in order to issue shares in respect of these applications the Board of the Company has resolved to make use of part of the £10m over-allotment facility as provided for under the Terms and Conditions of the Offers.

The extent to which the over-allotment facility is utilised for further issues will depend on the availability of new investment opportunities over the next few months, in relation to which the Board of the Company will provide an update in due course.

Terms defined in the joint prospectus issued by Amati VCT plc and Amati VCT 2 plc in October 2017 have the same meaning in this announcement.

The Board of the Company does not consider this announcement to contain market sensitive information. 

For further information please contact Rachel le Derf on 0131 503 9104 or email info@amatiglobal.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUVRVRWUAVAAR
Date   Source Headline
15th Jan 20247:00 amRNSIssue of Equity
12th Jan 20242:51 pmRNSNet Asset Value(s)
5th Jan 20245:29 pmRNSNet Asset Value(s)
3rd Jan 202412:44 pmRNSNet Asset Value(s)
2nd Jan 20241:58 pmRNSTotal Voting Rights
21st Dec 20233:45 pmRNSNet Asset Value(s)
20th Dec 20233:56 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 202311:01 amRNSNet Asset Value(s)
4th Dec 202310:44 amRNSNet Asset Value(s)
1st Dec 202310:25 amRNSTotal Voting Rights
30th Nov 20234:02 pmRNSDividend Declaration
28th Nov 202312:46 pmRNSTransaction in Own Shares
27th Nov 202312:16 pmRNSDirector/PDMR Shareholding
27th Nov 20239:34 amRNSIssue of Equity
24th Nov 20234:23 pmRNSNet Asset Value(s)
20th Nov 202310:19 amRNSNet Asset Value(s)
17th Nov 20234:46 pmRNSTransaction in Own Shares
13th Nov 20239:31 amRNSNet Asset Value(s)
6th Nov 202312:27 pmRNSTransaction in Own Shares
2nd Nov 20239:34 amRNSNet Asset Value(s)
1st Nov 202310:01 amRNSTotal Voting Rights
30th Oct 20233:52 pmRNSTransaction in Own Shares
30th Oct 202310:19 amRNSNet Asset Value(s)
23rd Oct 20234:50 pmRNSNet Asset Value(s)
19th Oct 202311:31 amRNSTransaction in Own Shares
16th Oct 202311:43 amRNSTransaction in Own Shares
13th Oct 20235:41 pmRNSNet Asset Value(s)
9th Oct 202312:54 pmRNSTransaction in Own Shares
6th Oct 20235:23 pmRNSNet Asset Value(s)
6th Oct 20237:01 amRNSDividend Declaration
6th Oct 20237:00 amRNSHalf-year Report
3rd Oct 202312:07 pmRNSNet Asset Value(s)
2nd Oct 202310:31 amRNSTotal Voting Rights
25th Sep 20239:53 amRNSNet Asset Value(s)
22nd Sep 20231:11 pmRNSTransaction in Own Shares
18th Sep 202312:10 pmRNSNet Asset Value(s)
14th Sep 202312:17 pmRNSTransaction in Own Shares
11th Sep 20239:21 amRNSNet Asset Value(s)
5th Sep 202311:24 amRNSCompliance with Market Abuse Regulation
4th Sep 202310:43 amRNSNet Asset Value(s)
1st Sep 202311:33 amRNSTotal Voting Rights
31st Aug 20234:44 pmRNSTransaction in Own Shares
25th Aug 20233:20 pmRNSNet Asset Value(s)
18th Aug 20235:18 pmRNSNet Asset Value(s)
15th Aug 20234:13 pmRNSTransaction in Own Shares
11th Aug 20234:20 pmRNSNet Asset Value(s)
4th Aug 20234:17 pmRNSNet Asset Value(s)
2nd Aug 20234:18 pmRNSTransaction in Own Shares
1st Aug 20234:49 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.